Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Jan 2014 16:06

RNS Number : 6163Y
Royal Bank of Scotland Group PLC
27 January 2014
 

Royal Bank of Scotland Group plc - Trading Update

 

27 January 2014

 

The Royal Bank of Scotland Group plc ("RBS" or "the Group") will announce its full year results on 27 February 2014, which will reflect the following:

 

Provisions for litigation and conduct related matters

 

· The Board of RBS has decided to provide £1.9 billion covering various claims and conduct related matters affecting Group companies, primarily those related to mortgage-backed securities and securities related litigation, following recent third party litigation settlements and regulatory decisions.

 

· An additional £465 million provision for Payment Protection Insurance redress and related costs. Q4 2013 claims experience has continued at previous rates (c.£225 million per quarter) rather than declining as anticipated and claims are now expected to continue for a longer period. The cumulative provision is £3.1 billion, of which £2.2 billion had been utilised at 31 December 2013. The remaining provision of £0.9 billion covers approximately twelve months of redress and administrative expenses.

 

· A further £500 million provision for Interest Rate Hedging Products redress and administration costs. The increase in provision reflects both higher volumes and anticipated redress payments, recalibration of our methodology based on experience during Q4 2013, and additional administration charges. The cumulative provision, including expenses, was £1.25 billion at 31 December 2013.

 

Operating Performance

 

At its Q3 2013 results, RBS announced its intention to create RBS Capital Resolution, which was established on 1 January 2014. To reflect this new strategy, RBS recognised additional impairments and asset valuation adjustments in Q4 2013. In aggregate these are expected to be in the range of £4.0 to £4.5 billion as previously announced on 1 November 2013.

 

Non-Core asset reduction was accelerated in Q4 2013. As a result, Third Party Assets at 31 December 2013 were below previous guidance of £35 billion. The cost of this faster de-risking process will be reflected in the division's operating loss for Q4 2013.

 

Q4 2013 Core operating expenses include c.£200 million of additional provisions for various conduct related and legal expenses, in addition to those detailed above.

 

As anticipated, Markets performance in Q4 2013 reflected normal seasonal trends.

 

Capital

 

As indicated in the capital plan announced with our Q3 2013 results, RBS continues to target a fully loaded Basel III Core Tier 1 ratio of c.11% by the end of 2015 and 12% or above by the end of 2016. The impact of the provisions highlighted above was reflected in our future capital plan, outlined at the Q3 2013 results presentation.

 

On a reported basis, RBS expects to report a Core Tier 1 ratio of around 11% as at 31 December 2013. On a fully loaded Basel III basis, the Group's equivalent Core Tier 1 ratio is expected to be in the range of 8.1% and 8.5%.

 

The figures quoted in this statement are preliminary estimates and unaudited. The normal year end results processes are currently underway. The RBS Full Year 2013 Results and Strategy presentation will be held on 27 February 2014 and available to view via webcast at www.investors.rbs.com/financial_result

 

 

For further information:

 

Investors

RBS Group Investor Relations

+44 (0) 207 672 1758

 

Media

RBS Group Media Relations

+44 (0) 131 523 4205

 

 

This release contains 'forward-looking statements' as that term is defined in the United States Private Securities Litigation Reform Act of 1995. Forward looking statements are statements that are not historical facts and can be identified by the use of forward-looking terminology such as statements that include the words 'expect', 'estimate', 'project', 'anticipate', 'believes', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'will', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on such expressions or by the forward looking nature of discussions of strategy, plans, targets and intentions. . These statements are based on current plans, estimates and projections, and are subject to inherent risks, uncertainties and other factors which could cause actual results to differ materially from the future results expressed or implied by such forward-looking statements. The forward-looking statements contained in this release speak only as of the date of this announcement, and the Group does not undertake to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The information, statements and opinions contained in this document do not constitute a public offer under any applicable legislation or an offer to sell or solicitation of any offer to buy any securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKODKABKDPDB
Date   Source Headline
31st Jan 20185:12 pmRNSTotal Voting Rights
29th Jan 20182:27 pmRNSDirector/PDMR Shareholding
3rd Jan 20185:05 pmRNSPublication of Suppl.Prospcts
29th Dec 20171:20 pmRNSDirector/PDMR Shareholding
29th Dec 20171:20 pmRNSTotal Voting Rights
21st Dec 201710:14 amRNSSegmental Reporting Restatement Document
21st Dec 20179:00 amRNSDirectorate Change
7th Dec 20175:23 pmRNSPublication of a Prospectus
30th Nov 20173:29 pmRNSTotal Voting Rights
29th Nov 201711:51 amRNSHolding(s) in Company
28th Nov 20177:06 amRNS2017 Bank of England Stress Test Results
23rd Nov 20175:00 pmRNSDividend Declaration
21st Nov 20173:53 pmRNSUpdate on Ring-Fencing Plans
8th Nov 20174:34 pmRNSHolding(s) in Company
8th Nov 20173:28 pmRNSDirector/PDMR Shareholding
8th Nov 20172:40 pmRNSHolding(s) in Company
3rd Nov 201711:55 amRNSHolding(s) in Company
31st Oct 20171:41 pmRNSTotal Voting Rights
27th Oct 20174:17 pmRNSPublication of Suppl.Prospcts
27th Oct 20177:00 amRNSQ3 2017 Interim Management Statement
26th Oct 20172:13 pmRNSHolding(s) in Company
25th Oct 20171:53 pmRNSHolding(s) in Company
24th Oct 20175:37 pmRNSDisposal of shareholdings in Euroclear plc
24th Oct 20171:35 pmRNSHolding(s) in Company
24th Oct 201712:56 pmRNSHolding(s) in Company
20th Oct 201712:03 pmRNSHolding(s) in Company
17th Oct 20171:42 pmRNSHolding(s) in Company
10th Oct 20175:11 pmRNSNotices of Redemption
5th Oct 201712:24 pmRNSBlock listing Interim Review
29th Sep 20172:39 pmRNSTotal Voting Rights
29th Sep 20171:55 pmRNSThe Royal Bank of Scotland N.V. Interim Results
27th Sep 20176:20 pmRNSAllotment and Issue of New Ordinary Shares
26th Sep 20179:00 amRNSBank of America Merrill Lynch Conference
18th Sep 20175:15 pmRNSEC formally approves Alternative Remedies Package
18th Sep 20171:17 pmRNSHolding(s) in Company
14th Sep 20173:19 pmRNSHolding(s) in Company
11th Sep 20171:30 pmRNSBarclays Global Financial Services Conference
1st Sep 20172:35 pmRNSDirectorate Change
31st Aug 20179:50 amRNSTotal Voting Rights
23rd Aug 20176:11 pmRNSDividend Declaration
7th Aug 20175:43 pmRNSNotice of Redemption
7th Aug 20172:21 pmRNSPublication of Suppl.Prospcts
7th Aug 20177:00 amRNSRedemption of Non-cumulative Dollar Pref. Shares
4th Aug 20174:48 pmRNSRedemption of Non-cumulative Preference Shares
4th Aug 20177:20 amRNSTechnology & Innovation Committee
4th Aug 20177:00 amRNSHalf-year Report
31st Jul 20172:29 pmRNSTotal Voting Rights
26th Jul 20174:31 pmRNSUpdate on RBS's remaining State Aid obligation
12th Jul 20171:34 pmRNSSettlement reached with the FHFA re US RMBS claims
12th Jul 201711:00 amRNSTR-1 Notification of Major Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.